Skip to main content
. 2018 Feb 12;19(2):346–360. doi: 10.5811/westjem.2017.9.35671

Table 3.

Association of variables with 30-day anticoagulation initiation for high-risk patients (ATRIA score ≥7) with atrial fibrillation and flutter discharged home from the emergency department

Variable Anticoagulation initiation in ED or within 30 days

Univariate models Multivariable model


Odds ratio* 95% CI Adjusted odds ratio* 95% CI
Age, per year 0.93 0.89, 0.96 0.89 0.82, 0.96
Gender
 Female Reference -- Reference --
 Male 0.65 0.41, 1.04 1.58 0.91, 2.74
Race
 White Reference -- Reference --
 Non-white 1.27 0.69, 2.34 0.85 0.42, 1.74
Clinical characteristics at index ED visit
 Rhythm diagnosis
  AF, any Reference -- Reference --
  AFL, isolated 3.18 1.38, 7.33 2.20 0.84, 5.77
 AF/FL history
  Prior AF/FL diagnosis Reference -- Reference --
  New AF/FL diagnosis 2.93 1.81, 4.73 3.10 1.72, 5.58
 Onset of symptoms
  Recent-onset (<48 hrs) Reference -- Reference --
  Not recent (≥48 hrs) 2.06 1.15, 3.69 2.31 1.03, 5.21
  Unclear 1.54 0.91, 2.62 1.10 0.54, 2.23
 AF/AFL categorization
  Chronic/unremitting Reference -- Reference --
  Intermittent/recurrent 2.61 1.19, 5.74 4.56 1.65, 12.60
  Unclear 3.44 1.42, 8.38 3.43 1.14, 10.34
 ED cardiologist consultation
  No Reference -- Reference --
  Yes 2.47 1.54, 3.96 1.89 1.10,3.23
 ED discharge rhythm
  Sinus rhythm Reference -- Reference --
  AF/FL 1.67 1.05, 2.64 2.65 1.35, 5.21
 ATRIA stroke risk
  Score, per point increase above 6 0.90 0.84, 0.96 1.10 0.96, 1.26
 HAS-BLED hemorrhage risk score
  Score, per point increase 0.86 0.73, 1.02
  Categorical
   Low risk (<3) Reference --
   High risk (≥3) 0.59 0.34, 1.01

ED, emergency department; AF, atrial fibrillation; AFL, atrial flutter; AF/FL, atrial fibrillation or flutter; ATRIA, Anticoagulation and Risk Factors in Atrial Fibrillation; HAS-BLED, Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly (>65 years), Drugs or alcohol; CI, confidence interval.

*

Reference group includes individuals with no anticoagulation initiation by 30 days after the index ED visit.